EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
04/26/2024
Back to search
Official data from USPTO
YOUR FOUNTAIN OF YOUTH
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
46
Latest update
04/26/2024
Trademark type
Combined
Nice classes
1, 5, 42, 44
Filing date
05/25/2021
Registration date
06/20/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/20/2023
Last transaction
04/26/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
5
Owner type
99
Owner location
CY
Examiner
LOZEAU, BRANDON
Law office
N90
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
KWALATA TRADING LIMITED
Representatives
Julianne Abelman Womble Bond Dickinson (US) LLP
Technical classification
Nice Classes
Class 1Class 5Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Stem cell preparations used for research of peripheral neuropathyperipheral vascular diseasecritical limb ischemiawound careend-stage heart diseasesangina pectorisischemic and dilated cardiomyopathyCOPDidiopathic pulmonary hypertension and other diseases of ischemia; biomedical autologous preparations in the nature of hematopoietic stem cells that include a synergetic cell population of angiogenic cell precursors used for researchother experiments of minor health disorders to prevent them from becoming severe health disorders
Class 5
Stem cell preparations used for the treatment of peripheral neuropathyperipheral vascular diseasecritical limb ischemiawound careend-stage heart diseasesangina pectorisischemic and dilated cardiomyopathyCOPDidiopathic pulmonary hypertension and other diseases of ischemia; biomedical autologous preparations in the nature of hematopoietic stem cells that include a synergetic cell population of angiogenic cell precursors used for the treatment of minor health disorders to prevent them from becoming severe health disordersto treat severe health disorders on an ongoing basis to sloweliminatereverse their progress
Class 42
Research and development in the field of bloodblood products being comprised of a synergistic cell population of stem cells including angiogenic cell precursorsblood testing; scientific research services in the field of blood and stem cells
Class 44
Services in the medical fieldmedical services performed in a laboratory for medical research companiesthe foregoing consisting of extractingprocessingculturingtestinginjecting or administering under medical supervision the products derived from blood and blood components being a novel human cell population; services in the medical fieldmedical services performed in a laboratory for medical research companiesthe foregoing consisting of selectingprocessingmanipulatingpurging and storing stem cells from blood and adding regenerative cells to the body
Publications
History of USPTO decisions and trademark events.
46 publications found
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
04/26/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
04/26/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
04/26/2024
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
10/10/2023
FICS
FINAL DISPOSITION NOTICE SENT TO IB
09/21/2023
FIMP
FINAL DISPOSITION PROCESSED
09/21/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
09/20/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/20/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
06/20/2023
GPNX
NOTIFICATION PROCESSED BY IB
04/05/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/04/2023
PUBO
PUBLISHED FOR OPPOSITION
04/04/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
03/15/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
03/15/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/15/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/27/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
02/27/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
02/27/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
02/27/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
02/27/2023
RFNT
REFUSAL PROCESSED BY IB
02/07/2023
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
01/31/2023
GNFR
FINAL REFUSAL E-MAILED
01/31/2023
CNFR
FINAL REFUSAL WRITTEN
01/31/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/10/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/09/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/09/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/27/2022
GNRT
NON-FINAL ACTION E-MAILED
12/27/2022
CNRT
NON-FINAL ACTION WRITTEN
12/27/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/13/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/13/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/13/2022
DOCK
ASSIGNED TO EXAMINER
10/20/2022
RFNT
REFUSAL PROCESSED BY IB
07/05/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
06/15/2022
RFRR
REFUSAL PROCESSED BY MPU
06/15/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
05/17/2022
CNRT
NON-FINAL ACTION WRITTEN
05/16/2022
CORN
CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
05/10/2022
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
05/02/2022
DOCK
ASSIGNED TO EXAMINER
02/07/2022
MAFR
APPLICATION FILING RECEIPT MAILED
11/12/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/08/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
11/04/2021
Continuous trademark protection
Get notified about every new filing that threatens YOUR FOUNTAIN OF YOUTH or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.